Professional congress organizer
Scientific Program
| The Tunisian Society of Infectious Diseases (TSID) 22th Tunisian Congress of Infectious Diseases |
 |
 |
The Federation of Arab Societies for Clinical Microbiology and Infectious Diseases (FASCMID) 2nd Arab Congress of Clinical Microbiology and Infectious Diseases |
| Hour | 8.00 | 9.00 | 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 17.00 | 18.00 | 19.00 | |||||||||
| Date | |||||||||||||||||||||
| Wednesday May 23, 2012 |
14.30 Registration |
19.00 – 20.30 General Assembly FASCMID |
|||||||||||||||||||
| 16.00 – 18.30 Workshop (Infective endocarditis) |
|||||||||||||||||||||
| 16.00 – 18.30 Workshop (HIV infection) |
|||||||||||||||||||||
| Thursday May 24, 2012 |
8.45 – 9.30 Lecture Leishmaniasis in Arab countries |
9.30 – 10.30 | Coffee break | 11.00 – 12.15 | 12.15– 13.30 Symposium (HIKMA ) |
Lunch Poster Session |
14.30 – 16.30 Community acquired infections |
Coffee break | 17.00 – 18.30 Infective endocarditis | 19.00 Opening ceremony |
|||||||||||
| Invasive fungal infections Infections in immunocompromised hosts |
19.30 – 21.00 Symposium (MSD ) |
||||||||||||||||||||
| Friday May 25, 2012 |
8.45 – 10.30 Tuberculosis |
Coffee break | 11.00 – 12.15 Vaccines | 12.15– 13.30 Symposium (PFIZER ) |
14.30 – 16.30 HIV infection |
Coffee break | 17.00 – 18.30 Viral hepatitis |
18.30 – 20.00 Symposium ( BMS ) |
|||||||||||||
| Saturday May 26, 2012 |
8.45 – 10.30 Bacterial resistance |
Coffee break |
11.30 - 13.00 Healthcare associated infections |
13.00 Closing ceremony |
|||||||||||||||||
22th Tunisian Congress of Infectious Diseases
2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases
| Scientific Programme | ||
|---|---|---|
| Wednesday May 23, 2012 | ||
| 16.00 – 18.30 | Workshop Infective endocarditis | |
|
Diagnostic tools of blood culture negative endocarditis (BCNE).
A. Znazen (Tunisia) |
||
|
Neurological complications of infective endocarditis.
J. Van Der Meer (Netherland) |
||
|
Infective endocarditis: special situation – compromised patients – unusual cause.
N. Kaabia (Tunisia) |
||
|
Management of prosthetic valve infective endocarditis.
A. Khayati (Tunisia) |
||
| 16.00 – 18.30 | Workshop HIV infection | |
|
First line antiretroviral therapy.
K. Marhoum El Filali (Morocco) |
||
|
Treatment of HIV/HBV and HIV/HCV co-infection.
D. Salmon-Ceron (France) |
||
|
Antiretroviral drug resistance: clinical consequences and management.
J. Mokhbat (Lebanon) |
||
|
Preventing mother to child transmission (PMTCT) of HIV.
M. Chakroun (Tunisia) |
||
| 19.00 – 20.30 | General Meeting FASCMID | |
| Thursday May 24, 2012 | ||
| 08.45 – 09.30 | Lecture: Leishmaniasis in Arab countries. K. Aoun (Tunisia) |
|
| 09.30 – 12.15 | Infections in immunocompromised hosts & Invasive fungal infections | |
| Chairpersons : | Ahmed Zribi (Tunisia) | |
| Tarak Ben Othmène (Tunisia) | ||
| Ali Ayadi (Tunisia) | ||
| 09.30 | Management of febrile neutropenia. C. Cordonnier (France) |
|
| 10.00 | Classification and new diagnostic methods for invasive fungal infections. S. Bretagne (France) |
|
| 10.30 | Coffee break (offered by MSD) | |
| 11.00 | Prophylaxis of invasive fungal infection in patient with haematological diseases or cancer. C. Cordonnier (France) |
|
| 11.30 | Current options for antifungal therapy of invasive candidiasis. S. Ladab (Tunisia) |
|
| 12.15 – 13.30 | Symposium HIKMA | |
| 13.30 – 14.30 | Poster Session I | |
| 14.30 – 16.30 | Community acquired infections | |
| Chairpersons : | Taoufik Ben Chaabane (Tunisia) | |
| Hicheme Ziglam (Libya) | ||
| Amel Kechrid (Tunisia) | ||
| 14.30 | Epidemiology of sexually transmitted infections in Arab countries. Z. Mhirsi (Tunisia) |
|
| 14.50 | Brucellosis: still a problem in Arab countries. J. Wadi (Jordan) |
|
| 15.10 | Classification and management of skin and soft tissue infections. E. Caumes (France) |
|
| 15.45 | Oral communications | |
| 15.45 | Prevalence and characteristics of Chlamydia trachomatis infection among three populations of Tunisian women with different risks of sexually transmitted infections. A. Znazen, H. Gharsallah, O. Frikha, N. Zribi, A. Hammami. (Sfax - Tunisia) |
|
| 16.00 | Febrile urinary tract infections in men. Report of 100 cases. F. Smaoui, A. Toumi, H. Ben Brahim, C. Loussaief, F. Ben Romdhane, N. Bouzouaïa, M. Chakroun. (Monastir - Tunisia) |
|
| 16.15 | Prevalence of Listeria among pregnant women in Libya. SS. Saky, A. Al Sherbini, A. Al Zahra. (Libya) |
|
| 16.30 | Coffee break (offered by MSD) | |
| 17.00 – 18.30 | Infective endocarditis | |
| Chairpersons : | Zuhayr Tabbara (Lebanon) | |
| Habib Gamra (Tunisia) | ||
| Amel Letaief (Tunisia) | ||
| 17.00 | Epidemiology of infective endocarditis in middle East. Z. Kanafani (Lebanon) |
|
| 17.25 | Controversies in prophylaxis of infective endocarditis. J. Van Der Meer (Netherland) |
|
| 17.50 | Oral communications | |
| 17.50 | Epidemiology of infective endocarditis in Tunisia: a multicenter retrospective study: 2001-2011. S. Hajri Ernez and the study group. ( Sousse - Tunisia) |
|
| 18.00 | Staphylococcal infective endocarditis. S. Ben Kahla, L. Abid, M. Koubâa, A. Znazen, D. Abid, I. Mâaloul, M. Akrout, S. mallek, F. Triki, M. Hentati, A. Hammami, M. Ben Jemâa, S. kammoun.(Sfax - Tunisia) |
|
| 18.10 | Right-sided infective endocarditis: A Tunisian experience. L. Ammari, A. Ghoubantini, A. Berriche, R. Abdelmalek, S. Aissa, F. Kanoun, B. Kilani, H. Tiouiri Benaissa, T. Ben Chaabane. (Tunis - Tunisia) |
|
| 18.20 | Infective Endocarditis at the American university of Beirut medical center: a 23-year experience. N. El Chakhtoura, JG. Sfeir, M. Yasmin, TA. Baban, SS. Kanj and ZA. Kanafani. (Beirut - Lebanon) |
|
| 19.00 – 19.30 | Opening Ceremony | |
| 19.30 – 21.00 | Symposium MSD | |
| Friday May 25, 2012 | ||
| 08.45 – 10.30 | Tuberculosis | |
| Chairpersons : | Noureddine Bouzouaïa (Tunisia) | |
| Jamel Wadi (Jordan) | ||
| Leila Slim (Tunisia) | ||
| 08.45 | Tuberculosis: epidemiology in north Africa and Middle east. M. Abdelaziz (WHO - EMRO) |
|
| 09.10 | The laboratory diagnosis of tuberculosis: update and news. D. Cirillo (Italy) |
|
| 09.40 | Multidrug resistant tuberculosis: epidemiology and treatment. E. Mokaddas (Kuwait) |
|
| 10.10 | Management of lymph node tuberculosis: Tunisian multicenter study. R. Abdelmalek (Tunisia) |
|
| 10.30 | Coffee break (offered by MSD) | |
| 11.00 – 12.15 | Vaccines | |
| Chairpersons : | Mohamed Daw (Libya) | |
| Mondher Gastli (Tunisia) | ||
| Henda Triki (Tunisia) | ||
| 11.00 | Perspective in novel vaccine development. R. Barbouche (Tunisia) |
|
| 11.20 | Recent Advances in malaria vaccine. A. Ahmed (USA) |
|
| 11.50 | Novel antibacterial vaccines. Novartis |
|
| 12.15 – 13.30 | Symposium Pfizer | |
| 13.30 – 14.30 | Poster Session II | |
| 14.30 – 16.30 | HIV infection | |
| Chairpersons : | Ahmed Hassi (Libya) | |
| Amine Slim (Tunisia) | ||
| Mohamed Ridha Kamoun (Tunisia) | ||
| 14.30 | Epidemiological situation and response to HIV infection in North Africa and the Middle East. H. Setayesh - H. Khatib (UNAIDS -MENA) |
|
| 14.50 | Tunisian recommendations on antiretroviral therapy: process, implementation and results. M. Ben Mamou - M. Chakroun (Tunisia) |
|
| 15.10 | Pre-exposure prophylaxis. J. Mokhbat (Lebanon) |
|
| 15.45 | Impact of HAART to prevent HIV transmission. A. Chatty (WHO - EMRO) |
|
| 16.30 | Coffee break (offered by MSD) | |
| 17.00 – 18.30 | Viral hepatitis | |
| Chairpersons : | Jacques Mokhbat (Lebanon) | |
| Fayçal Zouiten (Tunisia) | ||
| Azouz Msaddak (Tunisia) | ||
| 17.00 | Natural history and diagnosis of HBV infection: state of the art. O. Bahri (Tunisia) |
|
| 17.20 | Therapeutic strategies for HBV infection. J. Arends (Netherland) |
|
| 17.50 | HCV protease inhibitors in the treatment of naïve and experienced patients. D. Salmon-Ceron (France) |
|
| 18.10 | Treatment monitoring of chronic hepatitis C (efficacy and side effects). J. Boubaker (Tunisia) |
|
| 18.30 – 20.00 | Symposium BMS | |
| Saturday May 26, 2012 | ||
| 08.45 – 10.30 | Bacterial resistance | |
| Chairpersons : | Eimen Mokaddas (Kuwait) | |
| Saida Ben Redjeb (Tunisia) | ||
| Hanène Tiouiri Benaissa (Tunisia) | ||
| 08.45 | Carbapenemases: epidemiology, detection and therapeutic options. N. Woodford (UK) |
|
| 09.15 | Molecular characterization of community acquired methicillin-resistant Staphylococcus aureus and therapeutic impact. N. Ramdani Bouguessa (Algeria) |
|
| 09.45 | Contribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of multidrug resistant bacterial infections. F. Jehl (France) |
|
| 10.15 | Coffee break (offered by MSD). | |
| 10.30 – 11.30 | Poster Session III | |
| 11.30 – 13.00 | Healthcare associated infections. | |
| Chairpersons : | Nadjia Ramdani Bouguessa (Algeria) | |
| Abdelaziz Zorgani (Libya) | ||
| Fekri Abroug (Tunisia) | ||
| 11.30 | Prevalence and risk factors of healthcare-associated infections in Tunisia and Arabic countries. N. Borsali (Tunisia) |
|
| 12.00 | Healthcare-associated infections: prevention and control programs. C. Brun Buisson (France) |
|
| 12.30 | Oral communications | |
| 12.30 | Faecal carriage of multidrug-resistant bacteria (MDR) during a non-outbreak situation in Habib Bourguiba University hospital Sfax-Tunisia. B. Mnif, I. Jmal, E. Chiboub, S. Gouiaa, F Masmoudi, S. Sallemi, A. Hammami. (Sfax -Tunisia) |
|
| 12.45 | High rates of community acquired Panton-Valentine Leucocidin (PVL) positive methicillin resistant S. aureus (MRSA) infections in Rabta hospital of Tunisia. M. Zribi, H. Battikh, A. Masmoudi, J. Etienne, C. Fendri. (Tunis - Tunisia) |
|
| 13.00 | Closing Ceremony | |